Other News

Wegovy® receives FDA approval for cardiovascular risk reduction in adults with known heart disease and overweight or obesity

Wegovy® (semaglutide) injection 2.4 mg is the first-and-only medicine indicated for both reduction of the risk of major adverse cardiovascular events (MACE) such as death, heart attack, or stroke and for long-term weight management1 The approval is based on the results of SELECT, the…

InkSpace Imaging makes their advanced MRI coils available to Siemens Healthineers Magnetom Scanners

PLEASANTON, Calif., March 08, 2024 (GLOBE NEWSWIRE) — InkSpace Imaging proudly announces a major leap forward in advancing diagnostic imaging capabilities. Today, the company revealed the successful certification of its groundbreaking Snuggle™ and Silhouette™ MRI body arrays for compatibility with all Siemens Healthineers TIM 4G 3T Magnetom MRI scanners in […]

Getinge takes a leap forward in cardiovascular surgery with the 510(k) clearance for Vasoview Hemopro 3

GOTHENBURG, Sweden, March 8, 2024 /PRNewswire/ — Today, Getinge announces the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of the Vasoview Hemopro 3, the latest addition to the medtech company’s endoscopic vessel harvesting (EVH) solutions. Designed with customer centricity…

Advancing Healthcare Access: Genesis MedTech Teams Up with Silk Road Medical to Serve Patients affected by Carotid Artery Disease in China

WUXI, China, March 7, 2024 /PRNewswire/ — Silk Road Medical (NASDAQ: SILK), a medical device company based in California USA and Genesis MedTech Group have signed an exclusive distribution agreement to introduce the TCAR® core products, ENROUTE® Transcarotid Neuroprotection System and…

New Viz.ai Study Demonstrates Reduced Mortality Rates in Patients with Pulmonary Embolism

SAN FRANCISCO–(BUSINESS WIRE)– #ai–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced clinical data validating the impact of the Viz PE Solution in the management and outcomes of patients with pulmonary embolism (PE). The data was presented during the 2024 AVF (American Venous Forum) by Jacob Shapiro, M.D., vascular surgeon at TriHealth in Cincinnati, OH. The real-world study, “Shorter Time to Assessment and Anticoagulation with Decreased Mortalit

Nanoflex Robotics Installs First Remote-Ready Robotics System in North America for Vascular Interventions

The remote-ready robotics system, designed to be used for vascular interventions, was installed in The Jacobs Institute’s testing facility located within the University at Buffalo’s Canon Stroke and Vascular Research Center The Jacobs Institute site will be used for physician demonstrations and pre-clinical testing ZURICH, Switzerland, March 07, 2024 (GLOBE […]

Arch Biopartners Announces Dosing of First Patient in Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

TORONTO, March 07, 2024 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that patient recruitment and dosing has begun in Turkey for the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury […]

Premier Radiology Services Signs 5-Year Agreement to use RamSoft’s OmegaAI™ and Cloud-Based PowerServer® RIS/PACS Platforms for its 1,000+ Teleradiology Sites

RamSoft’s robust solutions provide Premier with unmatched speed and reliability for reading and processing images for its fast-growing teleradiology operations TORONTO and MIAMI, March 7, 2024 /PRNewswire/ – RamSoft, a global leader in novel cloud-based RIS/PACS radiology solutions for…